Iladatuzumab (MCDS0593A) is a monoclonal antibody targeting CD79B and is a naked antibody to the ADC compound Iladatuzumab vedotin, which has potential anticancer activity for the study of B-cell non-Hodgkins lymphoma (B-NHL).
Purity:
98.70%
CAS Number:
[1906205-76-2]
Target:
ADC Antibody|||Immunology/Inflammation related
T82078
* VAT and and shipping costs not included. Errors and price changes excepted